Drug intelligence / Profile preview

eggplant seed extract

Development stage: Preclinical
Lead developer: University of Kufa
Administration: Oral

Overview

Eggplant seed extract is a botanical preparation derived from the seeds of the eggplant (*Solanum melongena*), typically produced via ethanolic extraction. It contains various bioactive constituents, including phenols, flavonoids, and antioxidants. Research has investigated its potential in managing metabolic disorders such as hyperlipidemia. In experimental rat models, the extract has been evaluated for its ability to lower serum levels of total cholesterol, triglycerides, and low-density lipoproteins (LDL), although studies suggest it may be less potent than extracts derived from eggplant peels or conventional statin medications like atorvastatin.

Other names: Solanum melongena seed extractalcoholic eggplant seed extract

Beyond the preview

Go deeper on eggplant seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on eggplant seed extract.

Explore the full profile